Skip to main content
Download PDF

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

Multidisciplinary Respiratory Medicine volume 13, Article number: 31 (2018) Cite this article

The Original Article was published on 15 June 2018

Correction to: Multidisciplinary Respiratory Medicine (2018) 13:18 DOI: 10.1186/s40248-018-0131-x

After publication of the Original research article [1] it was brought to our attention that the sentence at pag 6 (between Fig. 3 and Fig. 4)) must be corrected as follows: “The mean duration of inactivity was 2.88 (0.63) at baseline; 1.53 (0.27) after 3; 1.40 (0.27) after 6, and 1.45 days (0.58) after twelve months (Anova: p = 0.11) in group A, while the corresponding duration in group B was 3.35 (0.63) at baseline; 0.60 (0.19) after 3; 1.10 (0.21) after 6, and 0.83 days (0.39) after 12 months (Anova; p <0.001), respectively.”

In addition at pag. 7 Fig. 5 entitled “Changes in mean duration of inactivity/p. over 12 months” must be substituted with the new Fig. 5 because there is a mistake regarding anova p = 0.11 and consequently in the whole image. This Correction shows the revised Fig. 5. The original article has been updated.

Fig. 5
figure 1

Changes in mean duration of inactivity/p. over 12 months

Full size image

Reference

  1. Negro D, et al. Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild to-moderate asthma. Multidisciplinary Respiratory Medicine. 2018;13:18.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy

    Roberto W. Dal Negro & Luca Bonadiman

  2. Research & Clinical Governance, Verona, Italy

    Paola Turco

Authors
  1. Roberto W. Dal Negro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Bonadiman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paola Turco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto W. Dal Negro.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dal Negro, R.W., Bonadiman, L. & Turco, P. Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma. Multidiscip Respir Med 13, 31 (2018). https://doi.org/10.1186/s40248-018-0144-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40248-018-0144-5

Multidisciplinary Respiratory Medicine

ISSN: 2049-6958

Contact us